The structural and functional integrity of the vascular endothelium is critical to normal lung function and vessel wall homeostasis. Injury to the endothelium results in increased permeability and altered endothelial cell (EC) metabolism and function. Oxidants generated by activated inflammatory cells play and important pathogenic role in EC barrier dysfunction and non-cardiogenic pulmonary edema. Although the mechanisms of oxidant-induced barrier dysfunction are not completely defined, oxidants function as bioregulators of EC signal transduction pathways. This proposal postulates that oxidant-mediated alterations of intracellular signals and effectors play a critical role in the pathophysiology of barrier dysfunction. To investigate this hypothesis, hydrogen peroxide, xanthine plus xanthine oxidase, and H2O2 plus sodium orthovanadate (diperoxovanadate, DPV) will be employed as model oxidants to define the mechanisms which regulate oxidant-mediated dysfunction. Based upon our preliminary data, we will test the hypothesis that oxidant-mediated protein kinase and phosphatase activities regulate EC barrier function via modulation of effector targets. ECs derived from several vascular sites will be examined following treatment with physiologically relevant doses of oxidant stress generated by H2O2 or X/XO.
In Specific Aim #1, overexpression and characterization of PKCalpha and epsilon in immortalized ECs will be carried out.
In Specific Aim #2, the role of PKC and PKC isoenzymes in the regulation of oxidant-mediated barrier dysfunction will be characterized.
In Specific Aim #3, oxidant-mediated protein tyrosine phosphorylation modulated by tyrosine kinases and phosphatases will be examined as potential barrier regulatory mechanisms. Finally, in Specific Aim #4, physiologically relevant targets of the transcellular signals generated in response to oxidants will be investigated. Specifically, focal adhesion protein and myosin light chain kinase will be investigated as potential targets for PKC and tyrosine kinases. These studies will provide a better understanding of the molecular mechanisms regulating oxidant-mediated barrier dysfunction, as key feature in the pathophysiology of oxidant-mediated vascular disorders.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL057260-06
Application #
6490573
Study Section
Special Emphasis Panel (ZRG4-ALTX-4 (01))
Program Officer
Gail, Dorothy
Project Start
1998-01-01
Project End
2003-12-31
Budget Start
2002-01-01
Budget End
2003-12-31
Support Year
6
Fiscal Year
2002
Total Cost
$228,208
Indirect Cost
Name
Johns Hopkins University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Ford, Lincoln E; Gilbert, Susan H (2007) Mechanism and significance of early, rapid shortening in sensitized airway smooth muscle. Can J Physiol Pharmacol 85:747-53
Usatyuk, Peter V; Fomin, Victor P; Shi, Shu et al. (2003) Role of Ca2+ in diperoxovanadate-induced cytoskeletal remodeling and endothelial cell barrier function. Am J Physiol Lung Cell Mol Physiol 285:L1006-17
Roy, Shukla; Parinandi, Narasimham; Zeigelstein, Roy et al. (2003) Hyperoxia alters phorbol ester-induced phospholipase D activation in bovine lung microvascular endothelial cells. Antioxid Redox Signal 5:217-28
Usatyuk, Peter V; Vepa, Suryanarayana; Watkins, Tonya et al. (2003) Redox regulation of reactive oxygen species-induced p38 MAP kinase activation and barrier dysfunction in lung microvascular endothelial cells. Antioxid Redox Signal 5:723-30
Cummings, Rhett; Parinandi, Narasimham; Wang, Lixin et al. (2002) Phospholipase D/phosphatidic acid signal transduction: role and physiological significance in lung. Mol Cell Biochem 234-235:99-109
Hu, Qinghua; Natarajan, Viswanathan; Ziegelstein, Roy C (2002) Phospholipase D regulates calcium oscillation frequency and nuclear factor-kappaB activity in histamine- stimulated human endothelial cells. Biochem Biophys Res Commun 292:325-32
Natarajan, V; Scribner, W M; Morris, A J et al. (2001) Role of p38 MAP kinase in diperoxovanadate-induced phospholipase D activation in endothelial cells. Am J Physiol Lung Cell Mol Physiol 281:L435-49
Gupta, M P; Ober, M D; Patterson, C et al. (2001) Nitric oxide attenuates H(2)O(2)-induced endothelial barrier dysfunction: mechanisms of protection. Am J Physiol Lung Cell Mol Physiol 280:L116-26
Shi, S; Garcia, J G; Roy, S et al. (2000) Involvement of c-Src in diperoxovanadate-induced endothelial cell barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 279:L441-51
Parinandi, N L; Scribner, W M; Vepa, S et al. (1999) Phospholipase D activation in endothelial cells is redox sensitive. Antioxid Redox Signal 1:193-210

Showing the most recent 10 out of 13 publications